1. "Did the Court of International Trade erroneously conclude that Algonquin controls the outcome of this action?"
2. "Is Section 232 facially unconstitutional on the ground that it does not impose...
1. "Whether the Court should vacate the district court’s judgment of noninfringement by Watson and direct entry of the consent judgment necessary to effectuate the parties’ agreement to settle, because:...
1. “Is Bio-Rad barred as a matter of law from asserting infringement under the doctrine of equivalents where it amended its claims to exclude the very terrain it now accuses,...
1. "Whether the asserted claims are invalid because: (1) They were anticipated by the prior art; or (2)They are not enabled and lack sufficient written description."
2. "Whether the asserted claims...
1. "Whether the CFC erred in holding that a NITU—which did not authorize third-party use of the railroad’s right-of-way but merely imposed a short administrative hold in the railroad’s voluntary...
"Whether the district court erred by finding claims 1, 2, 3, 7, 10, 11, 12, and 22 of the ’207 patent, which claim an improved cardiac monitoring device, to be...
1. "Whether, in determining that Patent No. 6,477,151 (the ‘151', or the '’151 Patent') is unenforceable, the district court committed an error of law in failing to apply a 'but...
1. "Whether the district court erred as a matter of law in determining that defendants who prevailed on two grounds—by obtaining (1) a final judgment based on a stipulation of...
1. "Did the Board err in its Final Written Decision in IPR2016-01156 finding that claims 1-15, 17-19 and 22-25 of the ’245 patent were not unpatentable as obvious under 35...
"Whether substantial evidence supports the jury’s verdict that Teva willfully induced infringement of GSK’s patented method of treating congestive heart failure where: (a) Teva encouraged the infringing use in promotional...
1. "Whether the patents-in-suit are invalid for [obviousness-type double patenting], where Immunex— which owns all substantial rights in those patents, including the ability to control patent prosecution—had already obtained earlier-expiring...
1. "Did the CAVC misinterpret Rule 23(a)’s commonality requirement to require that a proposed class of disabled veterans seeking class certification of claims alleging unreasonable system-wide delay always identify a...
"Congress has conferred limited authority on the judiciary to charge fees for access to electronic court records. These fees may be imposed 'as a charge for services rendered' to 'reimburse...
"I. Network-1’s Appeal
A. Independent Basis for Verdict: Does the evidence compel a finding of non-infringement irrespective of the challenged constructions?
B. Claim Construction:
1. Did the district court properly...
1. "Whether the district court clearly erred by finding that Nevro was irreparably harmed."
2. "Whether the district court erred legally by not holding the term 'nonparesthesia- producing . ....
1. "Whether the insurers’ statutory claims fail because Congress did not intend for insurers to receive damages as compensation for cost-sharing payments that Congress declined to fund."
2. "Whether the insurers’...
1. "Did the district court err in concluding that it cannot exercise personal jurisdiction over PerDiemCo even though (a) PerDiemCo expressly and repeatedly accused Trimble, a company based in northern...
"The primary issue on appeal is whether the Board erred in denying, based only on a § 101 patent eligibility challenge, Uniloc’s motion to amend the patent in this inter...
1. "Whether the district court erred in holding the asserted claims ineligible as abstract ideas under 35 U.S.C. §101?"
2. "Whether the district court erred in holding the claimed method and...
